Anti-ischemic effects of inotropic agents in experimental right ventricular infarction

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 7, 2009, Pages 941-948

  Hein, M ^a   Roehl, A B ^a   Baumert, J H ^a   Scherer, K ^a   Steendijk, P ^b   Rossaint, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT; INTERLEUKIN 6; LEVOSIMENDAN; MILRINONE; MYELOPEROXIDASE; MYOGLOBIN; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE; HEMODYNAMICS; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RIGHT CORONARY ARTERY; SWINE;

ANIMALS; BLOOD GAS ANALYSIS; CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HYDRAZONES; INFLAMMATION MEDIATORS; MILRINONE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; MYOGLOBIN; NEUTROPHIL INFILTRATION; PYRIDAZINES; SWINE; TROPONIN T;

EID: 67651207878     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.01994.x     Document Type: Article

References (34)

1. Zhao Z, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006 70 : 200 11.
2. Bowers TR, O'Neill WW, Grines C, Pica MC, Safian RD, Goldstein JA. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998 338 : 933 40.
3. Spear JF, Prabu SK, Galati D, Raza H, Anandatheerthavarada HK, Avadhani NG. Beta1-adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning. Am J Physiol Heart Circ Physiol 2007 292 : H2459 66.
4. Lazou A, Markou T, Zioga M, Vasara E, Efstathiou A, Gaitanaki C. Dopamine mimics the cardioprotective effect of ischemic preconditioning via activation of alpha1-adrenoceptors in the isolated rat heart. Physiol Res 2006 55 : 1 8.
5. + channels in rabbit hearts. J Pharmacol Exp Ther 2008 326 : 100 4.
6. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000 90 : 5 11.
7. Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemiareperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 1999 290 : 505 14.
8. 2+-contraction coupling due to inotropic drugs in isolated hearts. J Appl Physiol 2006 100 : 940 50.
9. Samimi-Fard S, Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Abreu-Gonzalez P. Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty. Int J Cardiol 2008 127 : 284 7.
10. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002 40 : 841 53.
11. Hein M, Roehl AB, Baumert JH, Bantes B, Bleilevens C, Bernstein N, Steendijk P, Rossaint R. Establishment of a porcine right ventricular infarction model for cardioprotective actions of xenon and isoflurane. Acta Anaesthesiol Scand 2008 52 : 1194 203.
12. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, 7th edn. Washington, DC : National Academy Press, 1996.
13. Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indices of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol 2008 294 : H238 48.
14. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981 101 : 593 600.
15. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985 14 : 157 67.
16. Miura T, Miki T. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 2008 103 : 501 13.
17. Rump AF, Acar D, Klaus W. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 1994 112 : 757 62.
18. Rechtman MP, Van der Zypp A, Majewski H. Amrinone reduces ischaemia-reperfusion injury in rat heart. Eur J Pharmacol 2000 402 : 255 62.
19. Sanada S, Kitakaze M, Papst PJ, Asanuma H, Node K, Takashima S, Asakura M, Ogita H, Liao Y, Sakata Y, Ogai A, Fukushima T, Yamada J, Shinozaki Y, Kuzuya T, Mori H, Terada N, Hori M. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation 2001 104 : 705 10.
20. Setoyama K, Kamimura R, Fujiki M, Misumi K, Miyahara K, Sakamoto H. Effects of olprinone on myocardial ischemia-reperfusion injury in dogs. J Vet Med Sci 2006 68 : 865 8.
21. Busk M, Maeng M, Kristensen J, Berg JS, Mortensen UM, Nielsen TT, Nielsen-Kudsk JE. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model. Cardiovasc Drugs Ther 2006 20 : 335 42.
22. Metzsch C, Liao Q, Steen S, Algotsson L. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model. Acta Anaesthesiol Scand 2007 51 : 86 93.
23. Rivo J, Raphael J, Drenger B, Berenshtein E, Chevion M, Gozal Y. Flumazenil mimics whereas midazolam abolishes ischemic preconditioning in a rabbit heart model of ischemia-reperfusion. Anesthesiology 2006 105 : 65 71.
24. Mullenheim J, Frassdorf J, Preckel B, Thamer V, Schlack W. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 2001 94 : 630 6.
25. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S. Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting. Ann Thorac Surg 2000 70 : 1551 7.
26. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999 43 : 860 78.
27. Galie N, Guarnieri C, Ussia GP, Zimarino M, Traini AM, Parlangeli R, Vaona I, Branzi A, Magnani B. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995 26 : 477 84.
28. Paraskevaidis IA, Parissis JT, Th Kremastinos D. Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. Curr Med Chem Cardiovasc Hematol Agents 2005 3 : 243 7.
29. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 1989 80 : 1816 27.
30. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002 53 : 31 47.
31. Agati L. Microvascular integrity after reperfusion therapy. Am Heart J 1999 138 : S76 8.
32. Karlson JA, Hopkins RW, Moran JM, Karlson KE. Long-term amiodarone administration protects against global myocardial ischemia. Ann Thorac Surg 1990 50 : 575 8.
33. Herzog WR, Schlossberg ML, MacMurdy KS, Edenbaum LR, Gerber MJ, Vogel RA, Serebruany VL. Timing of magnesium therapy affects experimental infarct size. Circulation 1995 92 : 2622 6.
34. Black SC, Gralinski MR, Friedrichs GS, Kilgore KS, Driscoll EM, Lucchesi BR. Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res 1995 29 : 629 36.